Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 174

1.

Loss of heterozygosity and promoter methylation, but not mutation, may underlie loss of TFF1 in gastric carcinoma.

Carvalho R, Kayademir T, Soares P, Canedo P, Sousa S, Oliveira C, Leistenschneider P, Seruca R, Gött P, Blin N, Carneiro F, Machado JC.

Lab Invest. 2002 Oct;82(10):1319-26.

PMID:
12379766
[PubMed - indexed for MEDLINE]
2.

Somatic mutations of the trefoil factor family 1 gene in gastric cancer.

Park WS, Oh RR, Park JY, Lee JH, Shin MS, Kim HS, Lee HK, Kim YS, Kim SY, Lee SH, Yoo NJ, Lee JY.

Gastroenterology. 2000 Sep;119(3):691-8.

PMID:
10982763
[PubMed - indexed for MEDLINE]
3.

Decreased abundance of trefoil factor 1 transcript in the majority of gastric carcinomas.

Beckler AD, Roche JK, Harper JC, Petroni G, Frierson HF Jr, Moskaluk CA, El-Rifai W, Powell SM.

Cancer. 2003 Nov 15;98(10):2184-91.

PMID:
14601088
[PubMed - indexed for MEDLINE]
Free Article
4.

Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues.

Leung WK, Yu J, Chan FK, To KF, Chan MW, Ebert MP, Ng EK, Chung SC, Malfertheiner P, Sung JJ.

J Pathol. 2002 Aug;197(5):582-8.

PMID:
12210076
[PubMed - indexed for MEDLINE]
5.

Lysyl oxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers.

Kaneda A, Wakazono K, Tsukamoto T, Watanabe N, Yagi Y, Tatematsu M, Kaminishi M, Sugimura T, Ushijima T.

Cancer Res. 2004 Sep 15;64(18):6410-5.

PMID:
15374948
[PubMed - indexed for MEDLINE]
Free Article
6.

Aberrant expression of trefoil factor family 1 in biliary epithelium in hepatolithiasis and cholangiocarcinoma.

Sasaki M, Tsuneyama K, Nakanuma Y.

Lab Invest. 2003 Oct;83(10):1403-13.

PMID:
14563942
[PubMed - indexed for MEDLINE]
7.

Hypermethylation of the TSLC1 gene promoter in primary gastric cancers and gastric cancer cell lines.

Honda T, Tamura G, Waki T, Jin Z, Sato K, Motoyama T, Kawata S, Kimura W, Nishizuka S, Murakami Y.

Jpn J Cancer Res. 2002 Aug;93(8):857-60.

PMID:
12716461
[PubMed - indexed for MEDLINE]
8.

Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma.

Byun DS, Cho K, Ryu BK, Lee MG, Park JI, Chae KS, Kim HJ, Chi SG.

Int J Cancer. 2003 Apr 10;104(3):318-27.

PMID:
12569555
[PubMed - indexed for MEDLINE]
9.

E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma.

Machado JC, Oliveira C, Carvalho R, Soares P, Berx G, Caldas C, Seruca R, Carneiro F, Sobrinho-Simöes M.

Oncogene. 2001 Mar 22;20(12):1525-8.

PMID:
11313896
[PubMed - indexed for MEDLINE]
Free Article
10.

Trefoil factor family-1 mutations enhance gastric cancer cell invasion through distinct signaling pathways.

Yio X, Diamond M, Zhang JY, Weinstein H, Wang LH, Werther L, Itzkowitz S.

Gastroenterology. 2006 May;130(6):1696-706.

PMID:
16697734
[PubMed - indexed for MEDLINE]
11.

Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression.

Wang LH, Kim SH, Lee JH, Choi YL, Kim YC, Park TS, Hong YC, Wu CF, Shin YK.

Clin Cancer Res. 2007 Jan 1;13(1):102-10.

PMID:
17200344
[PubMed - indexed for MEDLINE]
Free Article
12.

Genetic pathways of two types of gastric cancer.

Tahara E.

IARC Sci Publ. 2004;(157):327-49. Review.

PMID:
15055305
[PubMed - indexed for MEDLINE]
13.

Expression of TFF1, TFF2 and TFF3 in gastric cancer.

Kirikoshi H, Katoh M.

Int J Oncol. 2002 Sep;21(3):655-9.

PMID:
12168114
[PubMed - indexed for MEDLINE]
14.

Transcriptional regulation of the human trefoil factor, TFF1, by gastrin.

Khan ZE, Wang TC, Cui G, Chi AL, Dimaline R.

Gastroenterology. 2003 Aug;125(2):510-21.

PMID:
12891554
[PubMed - indexed for MEDLINE]
15.

Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma.

Sudo M, Chong JM, Sakuma K, Ushiku T, Uozaki H, Nagai H, Funata N, Matsumoto Y, Fukayama M.

Int J Cancer. 2004 Mar 20;109(2):194-9.

PMID:
14750169
[PubMed - indexed for MEDLINE]
16.

Fez1/lzts1 alterations in gastric carcinoma.

Vecchione A, Ishii H, Shiao YH, Trapasso F, Rugge M, Tamburrino JF, Murakumo Y, Alder H, Croce CM, Baffa R.

Clin Cancer Res. 2001 Jun;7(6):1546-52.

PMID:
11410489
[PubMed - indexed for MEDLINE]
Free Article
17.

Molecular characterization of undifferentiated-type gastric carcinoma.

Tamura G, Sato K, Akiyama S, Tsuchiya T, Endoh Y, Usuba O, Kimura W, Nishizuka S, Motoyama T.

Lab Invest. 2001 Apr;81(4):593-8.

PMID:
11304579
[PubMed - indexed for MEDLINE]
18.

Reduced expression of RAS protein activator like-1 in gastric cancer.

Seto M, Ohta M, Ikenoue T, Sugimoto T, Asaoka Y, Tada M, Mohri D, Kudo Y, Ijichi H, Tateishi K, Otsuka M, Hirata Y, Maeda S, Koike K, Omata M.

Int J Cancer. 2011 Mar 15;128(6):1293-302. doi: 10.1002/ijc.25459.

PMID:
20473946
[PubMed - indexed for MEDLINE]
19.

Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines.

Fukami T, Fukuhara H, Kuramochi M, Maruyama T, Isogai K, Sakamoto M, Takamoto S, Murakami Y.

Int J Cancer. 2003 Oct 20;107(1):53-9.

PMID:
12925956
[PubMed - indexed for MEDLINE]
20.

DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis.

Fujimoto J, Yasui W, Tahara H, Tahara E, Kudo Y, Yokozaki H, Tahara E.

Cancer Lett. 2000 Feb 28;149(1-2):125-34.

PMID:
10737716
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk